keyword
https://read.qxmd.com/read/38634529/paraneoplastic-calmodulin-kinase-like-vesicle-associated-protein-camkv-autoimmune-encephalitis
#1
JOURNAL ARTICLE
Michael Gilligan, Connie E Lesnick, Yong Guo, Michael J Bradshaw, Shafeeq S Ladha, Mihaela Nowak, Maulik P Shah, John R Wittenborn, Eati Basal, Shannon Hinson, Binxia Yang, Divyanshu Dubey, John R Mills, Sean J Pittock, Anastasia Zekeridou, Andrew McKeon
OBJECTIVES: To report an autoimmune paraneoplastic encephalitis characterized by immunoglobulin G (IgG) antibody targeting synaptic protein calmodulin kinase-like vesicle-associated (CAMKV). METHODS: Serum and cerebrospinal fluid (CSF) samples harboring unclassified antibodies on murine brain-based indirect immunofluorescence assay (IFA) were screened by human protein microarray. In 5 patients with identical cerebral IFA staining, CAMKV was identified as top-ranking candidate antigen...
April 18, 2024: Annals of Neurology
https://read.qxmd.com/read/38627134/rfc1-motifs-and-phenotypes
#2
REVIEW
V Delforge, C Tard, J-B Davion, K Dujardin, A Wissocq, C-M Dhaenens, E Mutez, V Huin
Biallelic intronic expansions (AAGGG)exp in intron 2 of the RFC1 gene have been shown to be a common cause of late-onset ataxia. Since their first description, the phenotypes, neurological damage, and pathogenic variants associated with the RFC1 gene have been frequently updated. Here, we review the various motifs, genetic variants, and phenotypes associated with the RFC1 gene. We searched PubMed for scientific articles published between March 1st, 2019, and January 15th, 2024. The motifs and phenotypes associated with the RFC1 gene are highly heterogeneous, making molecular diagnosis and clinical screening and investigation challenging...
April 15, 2024: Revue Neurologique
https://read.qxmd.com/read/38624158/divergent-associations-of-slow-wave-sleep-versus-rapid-eye-movement-sleep-with-plasma-amyloid-beta
#3
JOURNAL ARTICLE
Yevgenia Rosenblum, Mariana Pereira, Oliver Stange, Frederik D Weber, Leonore Bovy, Sofia Tzioridou, Elisa Lancini, David A Neville, Nadja Klein, Timo de Wolff, Mandy Stritzke, Iris Kersten, Manfred Uhr, Jurgen A H R Claassen, Axel Steiger, Marcel M Verbeek, Martin Dresler
OBJECTIVE: Recent evidence shows that during slow-wave sleep (SWS), the brain is cleared from potentially toxic metabolites, such as the amyloid-beta protein. Poor sleep or elevated cortisol levels can worsen amyloid-beta clearance, potentially leading to the formation of amyloid plaques, a neuropathological hallmark of Alzheimer disease. Here, we explored how nocturnal neural and endocrine activity affects amyloid-beta fluctuations in the peripheral blood. METHODS: We acquired simultaneous polysomnography and all-night blood sampling in 60 healthy volunteers aged 20-68 years...
April 16, 2024: Annals of Neurology
https://read.qxmd.com/read/38624073/characterizing-frontal-lobe-seizure-semiology-in-children
#4
JOURNAL ARTICLE
Thijs van Dalen, Jessica F Kirkham, Aswin Chari, Felice D'Arco, Friederike Moeller, Christin Eltze, J Helen Cross, Martin M Tisdall, Rachel C Thornton
OBJECTIVE: The objective was to analyze seizure semiology in pediatric frontal lobe epilepsy patients, considering age, to localize the seizure onset zone for surgical resection in focal epilepsy. METHODS: Fifty patients were identified retrospectively, who achieved seizure freedom after frontal lobe resective surgery at Great Ormond Street Hospital. Video-electroencephalography recordings of preoperative ictal seizure semiology were analyzed, stratifying the data based on resection region (mesial or lateral frontal lobe) and age at surgery (≤4 vs >4)...
April 16, 2024: Annals of Neurology
https://read.qxmd.com/read/38614929/a-developmental-component-to-huntington-s-disease
#5
REVIEW
L Ratié, S Humbert
Huntington's disease is a dominantly inherited disorder characterized by the dysfunction and death of cortical and striatal neurons. Striatal degeneration in Huntington's disease is due, at least in part, to defective cortical signalling to the striatum. Although Huntington's disease generally manifests at the adult stage, mouse and neuroimaging studies of presymptomatic mutation carriers suggest that it may affect neurodevelopment. In support of this notion, the development of the cortex is altered in mice with Huntington's disease and the foetuses of human Huntington's disease gene carriers...
April 12, 2024: Revue Neurologique
https://read.qxmd.com/read/38613459/quantitative-foot-muscle-magnetic-resonance-imaging-reliably-measures-disease-progression-in-children-and-adolescents-with-charcot-marie-tooth-disease-type-1a
#6
JOURNAL ARTICLE
Carolynne M Doherty, Paige Howard, Luke F O'Donnell, Riccardo Zuccarino, Stephen Wastling, Evelin Milev, Tina Banks, Sachit Shah, Nick Zafeiropoulos, Katherine J Stephens, Anna Sarkozy, Tiffany Grider, Shawna M E Feely, Adnan Manzur, Rosemary R Shy, Mariola Skorupinska, Menelaos Pipis, Emma Nicolaisen, Amy McDowell, Nuran Dilek, Alexander M Rossor, Matilde Laura, Christopher Clark, Francesco Muntoni, Daniel Thedens, John Thornton, Jasper M Morrow, Michael E Shy, Mary M Reilly
Quantitative muscle fat fraction (FF) responsiveness is lower in younger Charcot-Marie-Tooth disease type 1A (CMT1A) patients with lower baseline calf-level FF. We investigated the practicality, validity, and responsiveness of foot-level FF in this cohort involving 22 CMT1A patients and 14 controls. The mean baseline foot-level FF was 25.9 ± 20.3% in CMT1A patients, and the 365-day FF (n = 15) increased by 2.0 ± 2.4% (p < 0.001 vs controls)...
April 13, 2024: Annals of Neurology
https://read.qxmd.com/read/38609751/spinocerebellar-ataxia-27b-sca27b-a-frequent-late-onset-cerebellar-ataxia
#7
REVIEW
G Clément, S Puisieux, D Pellerin, B Brais, C Bonnet, M Renaud
Genetic cerebellar ataxias are still a diagnostic challenge, and yet not all of them have been identified. Very recently, in early 2023, a new cause of late-onset cerebellar ataxia (LOCA) was identified, spinocerebellar ataxia 27B (SCA27B). This is an autosomal dominant ataxia due to a GAA expansion in intron 1 of the FGF14 gene. Thanks to the many studies carried out since its discovery, it is now possible to define the clinical phenotype, its particularities, and the progression of SCA27B. It has also been established that it is one of the most frequent causes of LOCA...
April 11, 2024: Revue Neurologique
https://read.qxmd.com/read/38609750/c9orf72-hexanucleotide-repeat-expansion-from-als-and-ftd-to-a-broader-pathogenic-role
#8
REVIEW
C Sellier, P Corcia, P Vourc'h, L Dupuis
The major gene underlying monogenic forms of amyotrophic lateral sclerosis (ALS) and fronto-temporal dementia (FTD) is C9ORF72. The causative mutation in C9ORF72 is an abnormal hexanucleotide (G4C2) repeat expansion (HRE) located in the first intron of the gene. The aim of this review is to propose a comprehensive update on recent developments on clinical, biological and therapeutics aspects related to C9ORF72 in order to highlight the current understanding of genotype-phenotype correlations, and also on biological machinery leading to neuronal death...
April 11, 2024: Revue Neurologique
https://read.qxmd.com/read/38606939/current-state-of-evidence-for-neuroimaging-paradigms-in-management-of-acute-ischemic-stroke
#9
REVIEW
Amrou Sarraj, Deep K Pujara, Bruce Cv Campbell
Stroke is the chief differential diagnosis in patient presenting to the emergency room with abrupt onset focal neurological deficits. Neuroimaging, including non-contrast computed tomography (CT), magnetic resonance imaging (MRI), vascular and perfusion imaging, is a cornerstone in the diagnosis and treatment decision-making. This review examines the current state of evidence behind the different imaging paradigms for acute ischemic stroke diagnosis and treatment, including current recommendations from the guidelines...
April 12, 2024: Annals of Neurology
https://read.qxmd.com/read/38599976/anti-cd20-monoclonal-antibodies-in-multiple-sclerosis-rethinking-the-current-treatment-strategy
#10
REVIEW
S A Freeman, H Zéphir
Anti-CD20 monoclonal antibodies are highly-effective B-cell-depleting therapies in multiple sclerosis (MS). These treatments have expanded the arsenal of highly effective disease-modifying therapies, and have changed the landscape in understanding the pathophysiology of MS and the natural course of the disease. Nevertheless, these treatments come at the cost of immunosuppression and risk of serious infections, diminished vaccination response and treatment-related secondary hypogammaglobulinemia. However, the COVID pandemic has given way to a possibility of readapting these therapies, with most notably extended dosing intervals...
April 9, 2024: Revue Neurologique
https://read.qxmd.com/read/38594146/identification-and-characterization-of-repeat-expansions-in-neurological-disorders-methodologies-tools-and-strategies
#11
REVIEW
E Leitão, C Schröder, C Depienne
Tandem repeats are a common, highly polymorphic class of variation in human genomes. Their expansion beyond a pathogenic threshold is a process that contributes to a wide range of neurological and neuromuscular genetic disorders, of which over 60 have been identified to date. The last few years have seen a resurgence in repeat expansion discovery propelled by technological advancements, enabling the identification of over 20 novel repeat expansion disorders. These expansions can occur in coding or non-coding regions of genes, resulting in a range of pathogenic mechanisms...
April 8, 2024: Revue Neurologique
https://read.qxmd.com/read/38591875/diagnostic-utility-of-mog-antibody-testing-in-cerebrospinal-fluid
#12
JOURNAL ARTICLE
Vyanka Redenbaugh, James P Fryer, Laura Cacciaguerra, John J Chen, Tammy M Greenwood, Michael Gilligan, Smathorn Thakolwiboon, Masoud Majed, Nicholas H Chia, Andrew McKeon, John R Mills, A Sebastian Lopez Chiriboga, Jan-Mendelt Tillema, Binxia Yang, Yahya Abdulrahman, Kai Guo, Nisa Vorasoot, Cristina Valencia Sanchez, Deena A Tajfirouz, Michel Toledano, Anastasia Zekeridou, Divyanshu Dubey, Grace Y Gombolay, César Caparó-Zamalloa, Ilya Kister, Sean J Pittock, Eoin P Flanagan
OBJECTIVE: The aim of this study was to assess the diagnostic utility of cerebrospinal fluid (CSF) myelin oligodendrocyte glycoprotein antibodies (MOG-IgG) testing. METHODS: We retrospectively identified patients for CSF MOG-IgG testing from January 1, 1996, to May 1, 2023, at Mayo Clinic and other medical centers that sent CSF MOG-IgG for testing including: controls, 282; serum MOG-IgG positive MOG antibody-associated disease (MOGAD), 74; serum MOG-IgG negative high-risk phenotypes, 73; serum false positive MOG-IgG with alternative diagnoses, 18...
April 9, 2024: Annals of Neurology
https://read.qxmd.com/read/38582663/epidemiology-of-myasthenia-gravis-in-france-incidence-prevalence-and-comorbidities-based-on-national-healthcare-insurance-claims-data
#13
JOURNAL ARTICLE
S Keovilayhong, A Mulliez, L Feral, C Chenaf, P Clavelou, X Moisset, F Taithe, L Poncet Megemont
BACKGROUND: The European literature has reported high variability in the incidence and prevalence rates of myasthenia gravis (MG), but no specific epidemiological data for France have been published. This study aimed to assess the incidence and prevalence rates of myasthenia gravis in France based on data extracted from the French National Health Insurance Claims Database (the SNIIRAM database). METHODS: We conducted a retrospective repeated cross-sectional population study from 2008 to 2018 using a representative sample of the French population (Échantillon généraliste des bénéficiaires) covered by health insurance...
April 5, 2024: Revue Neurologique
https://read.qxmd.com/read/38582662/impact-of-multiple-sclerosis-on-employment-and-income-insights-from-a-random-sample-representative-of-private-sector-employees-in-france-using-longitudinal-administrative-data
#14
JOURNAL ARTICLE
E Leray, C Regaert, E Duguet, S Guillaume, S Pichetti, M Espagnacq
In France, few data sources are available to estimate the impact of multiple sclerosis (MS) on job retention and its consequences on the level of resources, especially in large representative samples. The aim of the present study was to measure impact of MS on employment rates, wages and income (including unemployment benefit, sickness benefit and disability pension) by comparing work trajectories of people living with MS with those of a matched control group. We used the HYGIE database, which is the result of the linkage of two administrative databases in the private sector for a random sample of over 900,000 people...
April 5, 2024: Revue Neurologique
https://read.qxmd.com/read/38582661/epileptic-encephalopathies-and-progressive-neurodegeneration
#15
REVIEW
R Guerrini, V Conti
Developmental encephalopathies (DE), epileptic encephalopathies (EE) and developmental and epileptic encephalopathies (DEE) are overlapping neurodevelopmental disorders characterized by early-onset, often severe epileptic seizures, developmental delay, or regression and have multiple etiologies. Classical nosology in child neurology distinguished progressive and nonprogressive conditions. A progressive course with global cognitive worsening in DEE is usually attributed to severe seizures and electroencephalographic abnormalities whose deleterious effects interfere with developmental processes both in an apparently healthy brain and in an anatomically compromised one...
April 5, 2024: Revue Neurologique
https://read.qxmd.com/read/38580500/gene-editing-as-a-therapeutic-strategy-for-spinocerebellar-ataxia-type-3
#16
REVIEW
N Déglon
Spinocerebellar ataxia type 3 (SCA3), also known as Machado-Joseph disease, is a neurodegenerative disease caused by expanded polyglutamine repeats in exon 10 of the ataxin-3 gene, ATXN3. The accumulation of mutant ATXN3 protein leads to severe clinical manifestations and premature death. Clinically, SCA3 pathology is characterized by progressive ataxia leading to motor incoordination that may affect balance, gait and speech, and neuropathologically by a progressive degeneration of the spinal cord and cerebellum, as well as the cerebral cortex and basal ganglia...
April 4, 2024: Revue Neurologique
https://read.qxmd.com/read/38578117/evaluating-the-effect-of-alzheimer-s-disease-related-biomarker-change-in-corticobasal-syndrome-and-progressive-supranuclear-palsy
#17
JOURNAL ARTICLE
Indira Garcia-Cordero, Chloe Anastassiadis, Abeer Khoja, Alonso Morales-Rivero, Simrika Thapa, Anna Vasilevskaya, Carly Davenport, Vishaal Sumra, Blas Couto, Namita Multani, Foad Taghdiri, Cassandra Anor, Karen Misquitta, Lawren Vandevrede, Hilary Heuer, David Tang-Wai, Bradford Dickerson, Alexander Pantelyat, Irene Litvan, Bradley Boeve, Julio C Rojas, Peter Ljubenkov, Edward Huey, Susan Fox, Gabor G Kovacs, Adam Boxer, Anthony Lang, M Carmela Tartaglia
OBJECTIVES: To evaluate the effect of Alzheimer's disease (AD) -related biomarker change on clinical features, brain atrophy and functional connectivity of patients with corticobasal syndrome (CBS) and progressive supranuclear palsy (PSP). METHODS: Data from patients with a clinical diagnosis of CBS, PSP, and AD and healthy controls were obtained from the 4-R-Tauopathy Neuroimaging Initiative 1 and 2, the Alzheimer's Disease Neuroimaging Initiative, and a local cohort from the Toronto Western Hospital...
April 5, 2024: Annals of Neurology
https://read.qxmd.com/read/38578115/blood-based-proteomics-for-adult-onset-focal-dystonias
#18
JOURNAL ARTICLE
Jigyasha Timsina, Ashok Dinasarapu, Gamze Kilic-Berkmen, John Budde, Yun Ju Sung, Adam M Klein, Carlos Cruchaga, H A Jinnah
OBJECTIVES: The adult-onset focal dystonias are characterized by over-active muscles leading to abnormal movements. For most cases, the etiology and pathogenesis remain unknown. In the current study, unbiased proteomics methods were used to identify potential changes in blood plasma proteins. METHODS: A large-scale unbiased proteomics screen was used to compare proteins (N = 6,345) in blood plasma of normal healthy controls (N = 49) with adult-onset focal dystonia (N = 143) consisting of specific subpopulations of cervical dystonia (N = 45), laryngeal dystonia (N = 49), and blepharospasm (N = 49)...
April 5, 2024: Annals of Neurology
https://read.qxmd.com/read/38568048/sex-differences-in-amyotrophic-lateral-sclerosis-survival-and-progression-a-multidimensional-analysis
#19
JOURNAL ARTICLE
Maurizio Grassano, Cristina Moglia, Francesca Palumbo, Emanuele Koumantakis, Paolo Cugnasco, Stefano Callegaro, Antonio Canosa, Umberto Manera, Rosario Vasta, Filippo De Mattei, Enrico Matteoni, Giuseppe Fuda, Paolina Salamone, Giulia Marchese, Federico Casale, Fabiola De Marchi, Letizia Mazzini, Gabriele Mora, Andrea Calvo, Adriano Chiò
OBJECTIVE: To investigate sex-related differences in amyotrophic lateral sclerosis (ALS) prognosis and their contributing factors. METHODS: Our primary cohort was the Piemonte and Aosta Register for ALS (PARALS); the Pooled Resource Open-Access ALS Clinical Trials (PRO-ACT) and the Answer ALS databases were used for validation. Survival analyses were conducted accounting for age and onset site. The roles of forced vital capacity and weight decline were explored through a causal mediation analysis...
April 3, 2024: Annals of Neurology
https://read.qxmd.com/read/38568044/high-frequency-of-cognitive-and-behavioral-impairment-in-amyotrophic-lateral-sclerosis-patients-with-sod1-pathogenic-variants
#20
JOURNAL ARTICLE
Andrea Calvo, Cristina Moglia, Antonio Canosa, Umberto Manera, Rosario Vasta, Maurizio Grassano, Margherita Daviddi, Filippo De Mattei, Enrico Matteoni, Salvatore Gallone, Maura Brunetti, Luca Sbaiz, Sara Cabras, Laura Peotta, Francesca Palumbo, Barbara Iazzolino, Gabriele Mora, Adriano Chiò
OBJECTIVE: While the cognitive-behavioral characteristics of amyotrophic lateral sclerosis (ALS) patients carrying C9orf72 pathological repeat expansion have been extensively studied, our understanding of those carrying SOD1 variants is mostly based on case reports. The aim of this paper is to extensively explore the cognitive-behavioral characteristics of a cohort of ALS patients carrying pathogenetic variants of SOD1 gene, comparing them to patients without pathogenetic variants of 46 ALS-related genes (wild-type [WT]-ALS) and healthy controls...
April 3, 2024: Annals of Neurology
keyword
keyword
15273
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.